Isatoribine
CAS No. 122970-40-5
Isatoribine( ANA245 | 7-Thia-8-oxoguanosine | Immunosine )
Catalog No. M10905 CAS No. 122970-40-5
Isatoribine (ANA245;7-Thia-8-oxoguanosine;Immunosine) is a nucleoside analogue, selective agonist of TLR7 with significant antiviral effect and mmunoenhancing activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 578 | Get Quote |
|
| 10MG | 822 | Get Quote |
|
| 25MG | 1233 | Get Quote |
|
| 50MG | 1665 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIsatoribine
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsatoribine (ANA245;7-Thia-8-oxoguanosine;Immunosine) is a nucleoside analogue, selective agonist of TLR7 with significant antiviral effect and mmunoenhancing activity.
-
DescriptionIsatoribine (ANA245;7-Thia-8-oxoguanosine;Immunosine) is a nucleoside analogue, selective agonist of TLR7 with significant antiviral effect and mmunoenhancing activity; stimulates proliferation of thymocytes in vitro, stimulates IL-2 production and the expression of activation markers (CD25 and CD71); reduces plasma virus concentration in chronic HCV infection; also increase the efficacy of a weakly immunogenic murine L1210 leukemia vaccine in vivo.HCV Infection Phase 2 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsANA245 | 7-Thia-8-oxoguanosine | Immunosine
-
PathwayImmunology/Inflammation
-
TargetTLR
-
RecptorTLR
-
Research AreaInfection
-
IndicationHCV Infection
Chemical Information
-
CAS Number122970-40-5
-
Formula Weight316.288
-
Molecular FormulaC10H12N4O6S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C1C(C(C(O1)N2C3=C(C(=O)NC(=N3)N)SC2=O)O)O)O
-
Chemical Name5-amino-3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4H-[1,3]thiazolo[4,5-d]pyrimidine-2,7-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Horsmans Y, et al. Hepatology. 2005 Sep;42(3):724-31.
2. Smee DF, et al. Antiviral Res. 1991 Mar-Apr;15(3):229-39.
3. Jin A, et al. Cell Immunol. 1990 Apr 1;126(2):414-9.
4. Sharma BS, et al. Cancer Immunol Immunother. 1991;33(2):109-14.
molnova catalog
related products
-
CU CPT 4a
CU CPT 4a is a selective TLR3 inhibitor (IC50: 3.44 μM in RAW 264.7 cells).
-
CU-T12-9
CU-T12-9 is a potent TLR1/2 agonist(EC50 of 52.9 nM in HEK-Blue hTLR2 SEAP assay).?It acts by activating the NFkB pathway, upregulating proinflammatory cytokines, and enhancing TLR1 and TLR2 dimerization.CU-T12-9 activates both the innate and the adaptive immune systems.
-
CU-CPT-8m
CU-CPT-8m is an toll-like receptor 8 (TLR8) antagonist (IC50 : 67 nM).
Cart
sales@molnova.com